1995： Company established

2004： Approved by CFDA for Phenylephrine HCl (GMP)

2007:   Oriental has been granted as high-tech enterprises

2009： Approved by CFDA for Phenylephrine HCl (GMP) (2nd time)

2013:   Obtained Written Confirmation

2014： Approved by US FDA

2015:   Doxylamine Succinate become our main product

2015:   Approved by CFDA for Phenylephrine HCl (GMP) (3rd time)

2016:   Approved by US FDA  (2nd time)

2016:   Passed the inspection of INTERTEK and SGS

2017:   The construction for the new production base in Shandong Binhai Industrial Zone

2018： Successful capping of new production base in Shandong Binhai

2019:   Approved by US FDA  (3rd time)

2019:   Obtained the Written Confirmation for Doxylamine Succinate、Phenylephrine Bitartrate、Etilefrine Hydrochloride